Analytical Excellence — Enabling Tomorrow’s Therapeutics
ProtaGene is a world-leading CRO partner for the biopharmaceutical and cell and gene therapy industries. From research through product commercialization, we provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as cell and gene therapy platforms.
Our deep history of analytical leadership in protein-based therapeutics stems from the merger of Protagen Protein Services in Europe and BioAnalytix in the US. In 2021, GeneWerk’s unique capabilities in vector safety, integration site analysis, and bioinformatics were added to our portfolio, establishing ProtaGene.
Our combined protein- and gene-based analytical platforms make it the leading analytic service provider across the biopharmaceutical and cell and gene therapy development spaces. The organization operates four sites in Europe and North America and works in advanced therapeutic platforms with leading biopharmaceutical and gene therapy companies worldwide.
More than 25 years of market experience and the comprehensive spectrum of validated analytical methods ensure the highest quality for customers in the pharmaceutical, biotech and life science industry.
Site |
Badges |
|
ProtaGene GmbH
10 Inselwiesenstraße
Heilbronn, BW, 74076
Germany
|
|
|
ProtaGene GmbH
Im Neuenheimer Feld 582
Heidelberg, BW, 69120
Germany
|
|
|
ProtaGene GmbH
15 Otto-Hahn-Straße
Dortmund, NRW, 44227
Germany
|
|
|
ProtaGene US inc.
4 Burlington Woods Drive
Burlington, MA, MA 01803
United States
|
|
|
ProtaGene
10 Inselwiesenstraße
Heilbronn, BW, 74076
Germany
|
|